Читать книгу Biologics, Biosimilars, and Biobetters - Группа авторов - Страница 92

Avonex^® is marketed in the United States by Biogen Idec and by Merck under the brand name Rebif^®. Gemany's Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and CinnaGen Company cloned Interferon beta‐1a and since 2006 the drug has been sold as CinnoVex^®, a biosimilar, in Iran.

Indication: Multiple sclerosis (MS)

Manufacturer: Biogen Idec

Global Sales in 2017: US$2.1 billion

Generic name: Interferon beta‐1a

Launch date: 1996